Literature DB >> 31502016

Editorial: A Novel Monoclonal Antibody-Targeting Angiogenesis by Inhibiting Secreted Frizzled-Related Protein 2.

Julie E Lang1,2, William W Tseng3,4, Irene Kang5,4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31502016      PMCID： PMC9049694          DOI： 10.1245/s10434-019-07801-1

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN： 1068-9265            Impact factor:   4.339


× No keyword cloud information.
  29 in total

Review 1.  Adverse effects of anticancer agents that target the VEGF pathway.

Authors:  Helen X Chen; Jessica N Cleck
Journal:  Nat Rev Clin Oncol       Date:  2009-07-07       Impact factor: 66.675

2.  Synergy between tumor immunotherapy and antiangiogenic therapy.

Authors:  Smita Nair; David Boczkowski; Benjamin Moeller; Mark Dewhirst; Johannes Vieweg; Eli Gilboa
Journal:  Blood       Date:  2003-04-10       Impact factor: 22.113

Review 3.  Tumor angiogenesis: therapeutic implications.

Authors:  J Folkman
Journal:  N Engl J Med       Date:  1971-11-18       Impact factor: 91.245

Review 4.  Improving immunotherapy outcomes with anti-angiogenic treatments and vice versa.

Authors:  Kabir A Khan; Robert S Kerbel
Journal:  Nat Rev Clin Oncol       Date:  2018-02-13       Impact factor: 66.675

Review 5.  Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges.

Authors:  Dai Fukumura; Jonas Kloepper; Zohreh Amoozgar; Dan G Duda; Rakesh K Jain
Journal:  Nat Rev Clin Oncol       Date:  2018-03-06       Impact factor: 66.675

Review 6.  Angiogenesis inhibitors: current strategies and future prospects.

Authors:  Kristina M Cook; William D Figg
Journal:  CA Cancer J Clin       Date:  2010-06-16       Impact factor: 508.702

7.  A novel function for programmed death ligand-1 regulation of angiogenesis.

Authors:  Yiping Jin; Sunil K Chauhan; Jaafar El Annan; Jaafar E I Annan; Peter T Sage; Arlene H Sharpe; Reza Dana
Journal:  Am J Pathol       Date:  2011-04       Impact factor: 4.307

8.  Secreted frizzle-related protein 2 stimulates angiogenesis via a calcineurin/NFAT signaling pathway.

Authors:  Andrew Courtwright; Sharareh Siamakpour-Reihani; Jack L Arbiser; Natalie Banet; Eleanor Hilliard; Levi Fried; Chad Livasy; David Ketelsen; Desh Bandhu Nepal; Charles M Perou; Cam Patterson; Nancy Klauber-Demore
Journal:  Cancer Res       Date:  2009-05-19       Impact factor: 12.701

Review 9.  Anti-angiogenic therapy for cancer: current progress, unresolved questions and future directions.

Authors:  Naveen S Vasudev; Andrew R Reynolds
Journal:  Angiogenesis       Date:  2014-01-31       Impact factor: 9.596

Review 10.  Anti-angiogenic agents for the treatment of solid tumors: Potential pathways, therapy and current strategies - A review.

Authors:  Ahmed M Al-Abd; Abdulmohsin J Alamoudi; Ashraf B Abdel-Naim; Thikryat A Neamatallah; Osama M Ashour
Journal:  J Adv Res       Date:  2017-06-27       Impact factor: 10.479
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.